AVEO Oncology
AVEO
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)
Categories
AVEO Oncology (AVEO) - Net assets
Net assets on the balance sheet as of September 2022 : $28.84 M
According to AVEO Oncology
's latest financial reports the company has $28.84 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AVEO Oncology - Net assets on balance sheet (from 2008 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2021-12-31 | $45.87 M | 29.97% |
| 2020-12-31 | $35.29 M | 137.73% |
| 2019-12-31 | $14.84 M | -154.53% |
| 2018-12-31 | $-27.23 M | -33.21% |
| 2017-12-31 | $-40.77 M | 2019.76% |
| 2016-12-31 | $-1.93 M | -111.16% |
| 2015-12-31 | $17.22 M | -16.4% |
| 2014-12-31 | $20.6 M | -70.54% |
| 2013-12-31 | $69.93 M | -41.2% |
| 2012-12-31 | $0.11 B | -46.79% |
| 2011-12-31 | $0.22 B | 211.47% |
| 2010-12-31 | $71.77 M | -691.81% |
| 2009-12-31 | $-12.13 M | -90.58% |
| 2008-12-31 | $-0.13 B | 30.7% |
| 2007-12-31 | $-98.46 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $10.86 B | 37,562.33% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 21,505.13% | 🇺🇸 USA |
 Biogen BIIB | $14.79 B | 51,206.64% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $25.97 B | 89,943.68% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $29.48 B | 102,118.76% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $18.74 M | -35.01% | 🇺🇸 USA |